文献速递肾小球疾病

尿C4d水平与伴肾小球新月体病变的IgA肾病疾病进展相关:一项队列研究

The level of urinary C4d is associated with disease progression in IgA nephropathy with glomerular crescentic lesions: a cohort study.
PubMed 文献 · Nephrol Dial Transplant · 2022-01-01

该队列研究纳入168例活检时存在不同比例新月体形成的IgA肾病患者,并另设107例独立验证队列,检测肾活检时尿C4d/肌酐水平。中位随访19个月(四分位距9-27)后53例(31.5%)达到终末期肾病,高尿C4d/肌酐水平与发生ESKD风险独立且显著相关(log转换C4d/肌酐每升高1个标准差,HR 7.623,95%CI 4.117-14.113)。

要点

  • 尿C4d/肌酐升高与更低的eGFR、大量蛋白尿、高血压及更严重的牛津M、E、T、C评分相关
  • 中位随访19个月(四分位距9-27)期间,53例(31.5%)达到终末期肾病
  • 高尿C4d/肌酐水平与ESKD风险独立且显著相关,HR 7.623(95%CI 4.117-14.113)

核心结论

  • 尿C4d/肌酐水平是一种潜在有用的生物标志物,与伴新月体的IgA肾病患者疾病严重程度和进展相关。

研究设计与样本

  • 研究纳入168例活检时存在不同比例新月体形成的IgA肾病患者,另纳入107例IgA肾病患者作为独立验证队列。
  • 肾活检标本采用免疫组化染色,肾活检时尿C4d水平采用酶联免疫吸附测定检测。
  • 主要终点为终末期肾病(ESKD)。

主要发现

  • 较高的尿C4d/肌酐水平与较低的估算肾小球滤过率(eGFR)、大量蛋白尿、高血压及更严重的牛津M、E、T和C评分相关。
  • 中位随访19个月(四分位距9-27)后,53例(31.5%)参与者达到ESKD。
  • 高尿C4d/肌酐水平与发生ESKD风险独立且显著相关,log转换C4d/肌酐每升高1个标准差的风险比HR为7.623(95%CI 4.117-14.113)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Positive glomerular C4d staining, representative of lectin pathway activation, has been proven to be associated with unfavorable outcomes in immunoglobulin A nephropathy (IgAN). Our previous study suggested that urinary C4d correlated positively with an increase in crescents while the relationship between urinary C4d and disease severity and progression remains unelucidated. METHODS: In this study we enrolled 168 patients diagnosed with IgAN with varying proportions of crescent formation at the time of biopsy. An independent cohort of 107 IgAN patients was enrolled for validation. Kidney biopsy specimens were stained using immunohistochemistry. Urinary C4d levels at renal biopsy were measured by enzyme-linked immunosorbent assay. The primary endpoint was end-stage kidney disease (ESKD). RESULTS: Higher urinary C4d/creatinine levels were associated with a lower estimated glomerular filtration rate (eGFR); massive proteinuria; hypertension and severe Oxford M, E, T and C scores. After a median follow-up of 19 months (interquartile range 9-27), 53 (31.5%) participants reached ESKD. High urinary C4d/creatinine levels were independently and significantly associated with a risk of developing ESKD [hazard ratio per standard deviation increment of log-transformed C4d/creatinine 7.623 (95% confidence interval 4.117-14.113)]. CONCLUSIONS: The urinary C4d/creatinine level is a potential useful biomarker that was associated with disease severity and progression in patients with IgAN and crescents.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Wang Z, Jiang Y, Chen P, et al. The level of urinary C4d is associated with disease progression in IgA nephropathy with glomerular crescentic lesions: a cohort study. Nephrol Dial Transplant. 2022. PMID: 35104893. doi:10.1093/ndt/gfac024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。